Wolfe Research Downgrades Zealand Pharma A/S (ZEAL:DC) (ZEAL) to Peerperform
Wolfe Research analyst Alexandria Hammond downgraded Zealand Pharma A/S (ZEAL:DC) (NASDAQ: ZEAL) from Outperform to Peerperform.The analyst comments "We downgrade ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)